Mehmet Fatih Kilicli

Dr. Mehmet Fatih Kilicli is the Chief Medical Officer at Medipol Acibadem District Hospital in Istanbul. He is a dual-specialist in endocrinology and reproductive endocrinology. Dr. Kilicli treats hormonal disorders and metabolic conditions for adult and pediatric patients.

Specialization and Areas of Focus

Dr. Kilicli treats a range of endocrine system disorders. He specializes in treating thyroid cancer, Type 2 diabetes, and adrenal gland disorders like adrenal adenoma. The doctor also treats metabolic issues, including obesity and nutritional disorders.

His specific focus includes:

• Hyperparathyroidism and Addison’s disease treatment
• Management of hirsutism and autoimmune thyroiditis
• Treatment of diffusive–toxic goiter
• Diagnostic thyroid function tests, including T3, T4, and TSH screening
• Hormonal health and reproductive endocrinology

Surgical and Therapeutic Procedures

Dr. Kilicli performs interventions for metabolic and hormonal conditions. He uses bioidentical hormone replacement therapy (BHRT) to balance patient hormone levels. For thyroid patients, he oversees radioiodine therapy and thyroidectomy procedures.

He also coordinates specialized treatments such as:

• Metabolic surgery for weight and blood sugar control
• Stem cell therapy for diabetes mellitus treatment
• Complex thyroid diagnostics and health check-ups
• Pediatric check-ups for hormonal development monitoring

Professional Experience

• 2024 – Present: Chief Medical Officer, Medipol Acibadem District Hospital, Turkey
• 2015 – 2024: Specialist, Bağcılar Medipol Mega University Hospital, Turkey
• 2002 – 2015: Department of Internal Medicine, Cumhuriyet University Faculty of Medicine, Turkey

Education and Training

• 1998 – Degree in Medicine, Gaziantep University Faculty of Medicine, Turkey
• 2002 – Internal Medicine Residency, Cumhuriyet University, Turkey